ClearBridge Advisors »

Kymera Therapeutics shares owned by ClearBridge Advisors

Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by ClearBridge Advisors from 13F filings

Historical chart of ClearBridge Advisors investment in Kymera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kymera Therapeutics held by ClearBridge Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kymera Therapeutics by ClearBridge Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $40M 347k 114.67

More positions owned by ClearBridge Advisors

NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Apple (AAPL)
Amazon (AMZN)
Broadcom (AVGO)
Taiwan Semiconductor Manufacturing Sponsored Ads (TSM)
Microsoft Corporation (MSFT)
Visa Com Cl A (V)
Meta Platforms Cl A (META)
Williams Companies (WMB)
ASML Holding NV N Y Registry Shs (ASML)
Palo Alto Networks (PANW)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)
Linde SHS (LIN)

View all positions for ClearBridge Advisors

Top funds holding Kymera Therapeutics

FMR
Baker Bros. Advisors
venBio Select Advisor
T. Rowe Price Associates
BlackRock
BVF
Wellington Management Company
Vanguard Portfolio Management
Siren
Vanguard Capital Management
Atlas Venture Life Science Advisors
State Street Corporation
Geode Capital Management
Capital Research Global Investors
Goldman Sachs Group

View all funds holding Kymera Therapeutics